| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | IDX Exchange | ID1000117203 ISIN |
| Indonesia Country | 1,266 Employees | 29 Oct 2025 Last Dividend | 12 Nov 2010 Last Split | - IPO Date |
PT Darya-Varia Laboratoria Tbk is a prominent entity in the Indonesian pharmaceutical and cosmetics industry, with a foundation laid in 1976. Based in Jakarta, Indonesia, it plays a vital role in manufacturing and trading a substantial range of pharmaceutical products and cosmetics. Operating across four main segments: Prescription Drugs, Consumer Health Products, Export, and Toll Manufacturing Services, and Services, the company has carved a niche for itself in the healthcare sector. As a subsidiary of Blue Sphere Singapore Pte. Ltd., it has expanded its reach beyond Indonesian borders, exporting products to countries including Malaysia, Myanmar, the Philippines, Singapore, Vietnam, and Mongolia.
Prescription Drugs: Offering a broad spectrum of prescription products targeting various health concerns such as cardiology, gastro-hepatology, antibiotics, women's healthcare, and more. This segment includes specialized areas like dermamedic, somatic, cough, and cold remedies, along with antibiotics and a comprehensive range of vitamins and food supplements. Additionally, it caters to niche medical areas including plastic surgery, general surgery, burn and trauma wound care, aesthetic medicine, ear healthcare, and central nerve systems treatments.
Consumer Health Products: This category features a diverse lineup, including:
Toll Manufacturing Services: PT Darya-Varia Laboratoria Tbk offers comprehensive toll manufacturing services, specializing in the production of soft gelatin capsules, sterile injections, and low volume solid products. These services extend their manufacturing expertise to other companies needing high-quality pharmaceutical manufacturing capabilities.
Export: Besides catering to the domestic market, the company has an established presence in the international arena, exporting its wide range of pharmaceutical products and services to several countries in the Southeast Asian region and beyond. This global outreach helps in promoting Indonesian pharmaceuticals on a wider scale.